FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200295744> ?p ?o ?g. }

• W4200295744 endingPage "S689" @default.
• W4200295744 startingPage "S688" @default.
• W4200295744 abstract "Abstract Background The National Institutes of Health Office of AIDS Research recommend that patients with HIV be prioritized for COVID-19 vaccination due to high rates of co-morbidities and sociodemographic risk factors that place them at increased risk for severe disease. However, COVID-19 vaccines were not distributed specifically to those in high-risk medical categories in Nebraska, and HIV clinics were not included in the state’s COVID-19 vaccine delivery system. As a result, barriers to vaccine uptake emerged and interventions to mitigate them were needed. Methods A multi-faceted and iterative program aimed at improving COVID-19 vaccine uptake was implemented at the University of Nebraska Medical Center’s (UNMC) HIV clinic in Omaha, Nebraska in January 2021. A multidisciplinary task force was established in late January 2021 and met on a weekly basis to provide staff and patient education, linkage to vaccines, and review and analysis of vaccine completion rates as shown in the figure. Outreach interventions were continuously revised based on patient and staff feedback as well as updated data and vaccine availability. Multidisciplinary COVID-19 Task Force Overview Overview of the outreach interventions and activities conducted by the COVID-19 task force Results All 1188 patients of the UNMC HIV clinic were ultimately eligible for the COVID-19 vaccine, but availability was on a rolling basis by age group, profession, county, and, ultimately, co-morbidities. 76% were male, 45.8% non-white, median age 48, and 73% had income less than 400% of federal poverty level. Of the 1188 eligible patients, 63.1% (n=751) had received at least one dose the COVID-19 vaccine and 59.3% (n=705) had completed the COVID-19 vaccine series by June 4, 2021. In comparison, 49.32% of the population of the state of Nebraska had initiated the COVID-19 vaccine series and 43.12% had completed the vaccine series by that date. Among our clinic patients, 27.9% (n=261) of those who had received at least one vaccine were assisted by our task force. 4.5% were noted to have a potential barrier at the time of outreach and these included hesitancy (3.5%), language (1.2%) and transportation (0.9%). Conclusion A multi-faceted and iterative program to improve COVID-19 vaccine uptake in a high-risk patient population resulted in high rates of vaccine completion. Disclosures Sara H. Bares, MD, Gilead Sciences (Grant/Research Support)Janssen (Grant/Research Support)ViiV Healthcare (Grant/Research Support)" @default.
• W4200295744 created "2021-12-31" @default.
• W4200295744 creator A5002778123 @default.
• W4200295744 creator A5004463563 @default.
• W4200295744 creator A5047994285 @default.
• W4200295744 creator A5052750202 @default.
• W4200295744 creator A5061753517 @default.
• W4200295744 creator A5067279276 @default.
• W4200295744 creator A5077333217 @default.
• W4200295744 creator A5077848997 @default.
• W4200295744 date "2021-11-01" @default.
• W4200295744 modified "2023-10-14" @default.
• W4200295744 title "1196. A Multi-faceted, Iterative Program to Increase COVID-19 Vaccine Uptake in a Midwestern HIV Clinic" @default.
• W4200295744 doi "https://doi.org/10.1093/ofid/ofab466.1388" @default.
• W4200295744 hasPublicationYear "2021" @default.
• W4200295744 type Work @default.
• W4200295744 citedByCount "0" @default.
• W4200295744 crossrefType "journal-article" @default.
• W4200295744 hasAuthorship W4200295744A5002778123 @default.
• W4200295744 hasAuthorship W4200295744A5004463563 @default.
• W4200295744 hasAuthorship W4200295744A5047994285 @default.
• W4200295744 hasAuthorship W4200295744A5052750202 @default.
• W4200295744 hasAuthorship W4200295744A5061753517 @default.
• W4200295744 hasAuthorship W4200295744A5067279276 @default.
• W4200295744 hasAuthorship W4200295744A5077333217 @default.
• W4200295744 hasAuthorship W4200295744A5077848997 @default.
• W4200295744 hasBestOaLocation W42002957441 @default.
• W4200295744 hasConcept C159110408 @default.
• W4200295744 hasConcept C17744445 @default.
• W4200295744 hasConcept C199539241 @default.
• W4200295744 hasConcept C203014093 @default.
• W4200295744 hasConcept C22070199 @default.
• W4200295744 hasConcept C27415008 @default.
• W4200295744 hasConcept C2781400479 @default.
• W4200295744 hasConcept C512399662 @default.
• W4200295744 hasConcept C71924100 @default.
• W4200295744 hasConcept C74909509 @default.
• W4200295744 hasConceptScore W4200295744C159110408 @default.
• W4200295744 hasConceptScore W4200295744C17744445 @default.
• W4200295744 hasConceptScore W4200295744C199539241 @default.
• W4200295744 hasConceptScore W4200295744C203014093 @default.
• W4200295744 hasConceptScore W4200295744C22070199 @default.
• W4200295744 hasConceptScore W4200295744C27415008 @default.
• W4200295744 hasConceptScore W4200295744C2781400479 @default.
• W4200295744 hasConceptScore W4200295744C512399662 @default.
• W4200295744 hasConceptScore W4200295744C71924100 @default.
• W4200295744 hasConceptScore W4200295744C74909509 @default.
• W4200295744 hasIssue "Supplement_1" @default.
• W4200295744 hasLocation W42002957441 @default.
• W4200295744 hasOpenAccess W4200295744 @default.
• W4200295744 hasPrimaryLocation W42002957441 @default.
• W4200295744 hasRelatedWork W1591771643 @default.
• W4200295744 hasRelatedWork W1909808695 @default.
• W4200295744 hasRelatedWork W2074091424 @default.
• W4200295744 hasRelatedWork W2083335006 @default.
• W4200295744 hasRelatedWork W2170918979 @default.
• W4200295744 hasRelatedWork W2335818225 @default.
• W4200295744 hasRelatedWork W2793660877 @default.
• W4200295744 hasRelatedWork W3126026968 @default.
• W4200295744 hasRelatedWork W4288096241 @default.
• W4200295744 hasRelatedWork W4379880357 @default.
• W4200295744 hasVolume "8" @default.
• W4200295744 isParatext "false" @default.
• W4200295744 isRetracted "false" @default.
• W4200295744 workType "article" @default.